Phospholipid vesicles (liposomes) have been used to entrap a range of cytotoxic drugs including actinomycin D with the aim of improving their therapeutic efficacy (Kimelberg & Mayhew, 1978) . However, evidence is now accumulating that liposomes undergo considerable disruption and release of their contents when in contact with plasma (Scherphof et al., 1978) . This may be a critical factor in determining the therapeutic effect of an entrapped cytotoxic drug, and we have therefore carried out studies of the stability of liposome-entrapped actinomycin D in the circulation after injection.
Mannitol-free actinomycin D was entrapped in the lipid phase of cationic liposomes (phosphatidylcholine/stearylamine/cholesterol in the molar ratio of 18 : 5 : 4) by the method previously described (Tyrrell et al., 1976) . By using a trace amount of [ 3H]actinomycin D, efficiency of entrapment was measured as 15.3 & 1.4% (mean _+ S.E.M. for 14 preparations) when the weight ratio of total lipid to actinomycin D was 100: 1. All liposome preparations were sonicated with 12 mm probe for 7.5min at 0°C (Heat Systems, W-225 R) to produce small multilamellar vesicles (mean diameter was 72 nm). Liposomes containing actinomycin D were separated from free drug by Sephadex G-50 column chromatography.
Liposome-entrapped actinomycin D (500,ug/g body wt.) was injected into the tail veins of groups of six mice, which were killed at time intervats up to 24 h later. Plasma was pooled at each time point and chromatographed on a Sepharose 6B column, eluted with phosphate-buffered saline (see Fig. la ). The total plasma activities, expressed as a percentage of the original injected dose, were 37, 17.5 and 1.5% at 1, 5 and 24h respectively. The data indicate that liposomes containing actinomycin D undergo gradual disruption in the circulation, and released drug becomes associated with albumin. This view is supported by further chromatographic studies on plasma from groups of mice injected with free actinomycin D, which have shown that 5 h after injection, 50% of the drug remaining in the circulation is eluted in the albumin fraction; the rest is eluted as free drug. Studies performed in vitro with double-labelled liposomes (prepared as above but containing 1 3Hlactinomycin D and I 14Clpho~phatidylcholine and incubated with whole plasma) have demonstrated a similar elution profile for the two labels (see Fig. lb ), suggesting that both phosphatidylcholine and actinomycin D bind to plasma albumin, with release of some drug in the free form.
Two published studies have reported an improved survival of animals treated with liposomally entrapped actinomycin D compared with free drug (Gregoriadis & Neerunjun, 1975; Rahman VOl. 8 et al., 1974) . However, in neither study was it possible to distinguish between reduced host toxicity and increased tumourcell kill as the mechanism responsible. We have examined the effect of intravenous liposomally entrapped actinomycin D (prepared as above) in a therapeutic-toxicity study on a solid murine tumour, the Ridgway osteosarcoma in AKR mice. Whereas 10 days after treatment free actinomycin D had inhibited tumour growth to 10% of control tumour weight at the dose of 0.3 ,ug/g, liposome-entrapped actinomycin D proved incapable of inhibiting growth to less than 68% of control tumour weight at doses up to 8 ,ug/g. For free actinomycin D the LD,, (dose lethal to 50% of animals at 10 days) was 0.8pg/g, whereas for liposomally entrapped actinomycin D, the LD,, was not reached at doses up to 8 ,ug/g.
The data from this study therefore indicate that administration of actinomycin D in liposomes results in an overall loss of activity, both against normal tissues and tumour, with no advantage over treatment with free drug. Nevertheless, liposome entrapment may still prove useful for those cytotoxic drugs with optimum anti-tumour activity when administered as a continued infusion, for example cytosine arabinoside (Mayhew et al., 1978) . However, the prolonged exposure of normal tissues that also ensues from the slow release of liposomally entrapped cytosine arabinoside may result in increased host toxicity (Rustum et al., 1979).
Elution volume (mi) Elution volume (ml) which were incubated with whole plasma (0.81111) for 30min at 37°C. (1978) Although, compared with the normal tissues of the body, tumours are disorganized, most tumours do show a distinctive structure (Evans, 1966) . In spite of marked variations, even among tumours deriving from a single type of cell, certain generalizations can be made. Firstly there are frequently areas of apparent partial re-differentiation, with tumour cells organized into structures which resemble particular areas of the parent or some other tissue (Braun, 1975) . Secondly, there are frequently areas in which the tumour has outgrown its blood supply, resulting in damage leading to eventual cell death and the formation of necrotic foci (Gallino, 1975) . Furthermore there may be a marked invasion of the tumour by host cells, particularily phagocytes, which may constitute an appreciable proportion of the tumour mass in some instances (Gallino, 1975) . Hence only a minority of the cells in a tumour may be 'healthy' tumour cells. Numerous methods have been used for the separation of cell types from tissues (Reid, 1979) . In some cases these methods involve the use of expensive equipment, but two relatively simple approaches have proved useful with liver, namely isopycnic banding in gradients of metrizamide (Seglen, 1974) and differential destruction of hepatocytes by treatment with Pronase (Mills & Zucker-Franklin, 1969) .
BIOCHEMICAL SOCIETY TRANSACTIONS
The UA hepatoma used in these studies occurred in a rat treated with ethionine (Reid, 1970) . Most of the experiments were carried out in the 282nd transplant generation. The generation time was approx. 18 days. Metrizamide was supplied by Nyegaard and Co. A/S (Oslo, Norway). Hepatoma cells were dispersed by the method used by Fry et al. (1976) for the separation of liver cells. Gradients were prepared by the method of Stone (1974) from metrizamide dissolved in Hepes 14-(2-hydroxyethy1)-1 -pipernine-ethanesulphonic acid1 buffer containing NaCl and KCl as described by Seglen (1974) . Centrifugation was carried out in the tubes of an MSE 3 x 23 ml swingout rotor. Glucose 6-phosphatase was assayed in the presence of 1OmM-tartrate as described by Dobrota et al. (1979) and corrected for the inhibition caused by assaying in the presence of high concentrations of metrizamide (Hinton et al., 1974) . Pronase treatment of hepatoma cell suspensions was carried out as described by van Berkel et al. (1975) .
Dispersed hepatoma cells formed a broad band in metrizamide gradients in the density range 1.06-1.13 g/ml. Most of the cells were, however, recovered at a density of 1.07g/ml. This is markedly lower than the density of 1.12g/ml which, in agreement with the results of Seglen (1976), we obtained for hepatocytes. So far we have obtained no evidence for enzymic differences between tumour cells of different densities, but there were marked differences in appearance, for the lower-density cells were loaded with very birefringent (presumably lipid) droplets. Studies on hepatoma sections suggests that these cells derive from a zone of fat-loaded cells, which is found several cells in from the large blood capillaries which traverse this tumour.
A considerable proportion of hepatoma cells were destroyed by Pronase, and it appeared that the cells that showed glucose 6-phosphatase activity were especially susceptible to Pronase treatment. The tumour cells that were not destroyed by Pronase banded over a very wide density range. The cells that survived
Pronase treatment showed no distinctive features. Both the fatloaded cells and the tumour cells that band at a density of 1.07 g/ml were destroyed by the Pronase treatment.
From these results we would draw the following conclusions. Firstly, isopycnic banding in metrizamide gradients is an effective method for separating tumour cells. Our results showed that a large proportion of the tumour cells banded at a density of about 1.07 g/ml, well separated from the abnormal fat-loaded cells and the dead cells, which, in agreement with the results of Seglen (1974) , were recovered as a pellet (indicating a density greater than 1.17g/ml). Further, we found that, even in the rather rapidly growing hepatoma used in these studies, a considerable proportion of the cells were destroyed by Pronase. The fact that cells containing glucose 6-phosphatase were selectively destroyed suggests that the true hepatoma cells are destroyed by Pronase and the remaining cells will be enriched in the host cells which invade transplanted tumours. It thus appears that the normal methods applied to the fractionation of liver cells can be used with transplanted hepatomas (in a single experiment we obtained similar results with a second, less dedefferentiated hepatoma). It would seem likely that comparison of the properties of 'healthy' tumour cells, obtained by methods such as those described above, with healthy hepatocytes would be more likely to yield information on the peculiarities of the cancerous cells than would comparison of whole homogenates.
